The emerging treatment of this peptide represents a major advance in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – providing https://tirzepatide-peptide125919.fare-blog.com/42425084/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment